_id
6915f451bc934aba376b228b
Ticker
SBLOF
Name
Shin Nippon Biomedical Laboratories, Ltd.
Exchange
PINK
Address
2438 Miyanoura-cho, Kagoshima, Japan, 891-1394
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.snbl.co.jp
Description
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
Last Close
9.36
Volume
-
Current Price
9.36
Change
0
Last Updated
2026-01-06T10:47:21.810Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
389673984
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-03-31
Revenue
8465743000
Cost Of Revenue
3720378000
Gross Profit
4745365000
Operating Expenses
6839108000
Operating Income
1626635000
Interest Expense
41923000
Pretax Income
2036781000
Net Income
1736614000
Eps
41.713510718491534
Dividends Per Share
-
Shares Outstanding
41631836
Income Tax Expense
-
EBITDA
-
Operating Margin
19.21432058591904
Total Other Income Expense Net
-
Cash
10274773000
Short Term Investments
336724000
Receivables
5778872000
Inventories
12373178000
Total Current Assets
30837713000
Property Plant Equipment
26357666000
Total Assets
76302347000
Payables
460527000
Short Term Debt
-
Long Term Debt
18147876000
Total Liabilities
42141715000
Equity
34114417000
Bs_currency_symbol
JPY
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
JPY
PE
11.7
PB
0.011422586355792038
ROE
5.090557461380624
ROA
2.2759640670030765
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
45
Deep Value Investing Score
7.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
6
Growth Investing Score
5.5
Momentum Investing Score
4.5
Net Net Investing Score
3.5
Quality Investing Score
5.5
Value Investing Score
8.5
Quarters > 0 > quarter
2024-03-31
Quarters > 0 > income Statement > revenue
8465743000
Quarters > 0 > income Statement > cost Of Revenue
3720378000
Quarters > 0 > income Statement > gross Profit
4745365000
Quarters > 0 > income Statement > operating Expenses
6839108000
Quarters > 0 > income Statement > operating Income
1626635000
Quarters > 0 > income Statement > interest Expense
41923000
Quarters > 0 > income Statement > pretax Income
2036781000
Quarters > 0 > income Statement > net Income
1736614000
Quarters > 0 > income Statement > eps
41.713510718491534
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
41631931
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
19.21432058591904
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
JPY
Quarters > 0 > balance Sheet > cash
10274773000
Quarters > 0 > balance Sheet > short Term Investments
336724000
Quarters > 0 > balance Sheet > receivables
5778872000
Quarters > 0 > balance Sheet > inventories
12373178000
Quarters > 0 > balance Sheet > total Current Assets
30837713000
Quarters > 0 > balance Sheet > property Plant Equipment
26357666000
Quarters > 0 > balance Sheet > total Assets
76302347000
Quarters > 0 > balance Sheet > payables
460527000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
18147876000
Quarters > 0 > balance Sheet > total Liabilities
42141715000
Quarters > 0 > balance Sheet > equity
34114417000
Quarters > 0 > balance Sheet > currency_symbol
JPY
Quarters > 0 > cash Flow > net Income
1736831000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
JPY
Quarters > 0 > ratios > PE
41.713510718491534
Quarters > 0 > ratios > PB
0.011422586355792038
Quarters > 0 > ratios > ROE
5.090557461380624
Quarters > 0 > ratios > ROA
2.2759640670030765
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2023-12-31
Quarters > 1 > income Statement > revenue
6100678000
Quarters > 1 > income Statement > cost Of Revenue
2916764000
Quarters > 1 > income Statement > gross Profit
3183913000
Quarters > 1 > income Statement > operating Expenses
5914427000
Quarters > 1 > income Statement > operating Income
186250000
Quarters > 1 > income Statement > interest Expense
34168000
Quarters > 1 > income Statement > pretax Income
1123842000
Quarters > 1 > income Statement > net Income
828478000
Quarters > 1 > income Statement > eps
19.90006180592488
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
41631931
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
3.0529393618217515
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
JPY
Quarters > 1 > balance Sheet > cash
12779319000
Quarters > 1 > balance Sheet > short Term Investments
223026000
Quarters > 1 > balance Sheet > receivables
5660479000
Quarters > 1 > balance Sheet > inventories
11935574000
Quarters > 1 > balance Sheet > total Current Assets
33442774000
Quarters > 1 > balance Sheet > property Plant Equipment
21348535000
Quarters > 1 > balance Sheet > total Assets
71371712000
Quarters > 1 > balance Sheet > payables
562925000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
18440047000
Quarters > 1 > balance Sheet > total Liabilities
41118727000
Quarters > 1 > balance Sheet > equity
30184277000
Quarters > 1 > balance Sheet > currency_symbol
JPY
Quarters > 1 > cash Flow > net Income
828000000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
JPY
Quarters > 1 > ratios > PE
19.90006180592488
Quarters > 1 > ratios > PB
0.012909862779221116
Quarters > 1 > ratios > ROE
2.7447336240652707
Quarters > 1 > ratios > ROA
1.1607932285553133
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2023-09-30
Quarters > 2 > income Statement > revenue
6079073000
Quarters > 2 > income Statement > cost Of Revenue
2919610000
Quarters > 2 > income Statement > gross Profit
3159463000
Quarters > 2 > income Statement > operating Expenses
4956676000
Quarters > 2 > income Statement > operating Income
1122397000
Quarters > 2 > income Statement > interest Expense
25747000
Quarters > 2 > income Statement > pretax Income
1872452000
Quarters > 2 > income Statement > net Income
1592858000
Quarters > 2 > income Statement > eps
38.26048808545537
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
41631931
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
18.46329201837188
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
JPY
Quarters > 2 > balance Sheet > cash
10721485000
Quarters > 2 > balance Sheet > short Term Investments
1293818000
Quarters > 2 > balance Sheet > receivables
5186248000
Quarters > 2 > balance Sheet > inventories
10003970000
Quarters > 2 > balance Sheet > total Current Assets
29801097000
Quarters > 2 > balance Sheet > property Plant Equipment
20901215000
Quarters > 2 > balance Sheet > total Assets
68558336000
Quarters > 2 > balance Sheet > payables
474086000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
13958582000
Quarters > 2 > balance Sheet > total Liabilities
36836031000
Quarters > 2 > balance Sheet > equity
31637576000
Quarters > 2 > balance Sheet > currency_symbol
JPY
Quarters > 2 > cash Flow > net Income
1593000000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
38.26048808545537
Quarters > 2 > ratios > PB
0.012316837236835083
Quarters > 2 > ratios > ROE
5.034703037931857
Quarters > 2 > ratios > ROA
2.323361523826949
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
5804974000
Quarters > 3 > income Statement > cost Of Revenue
2611139000
Quarters > 3 > income Statement > gross Profit
3193835000
Quarters > 3 > income Statement > operating Expenses
4577891000
Quarters > 3 > income Statement > operating Income
1227083000
Quarters > 3 > income Statement > interest Expense
36945000
Quarters > 3 > income Statement > pretax Income
1941369000
Quarters > 3 > income Statement > net Income
1373311000
Quarters > 3 > income Statement > eps
32.98696378027721
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
41631931
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
21.138475383352276
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
JPY
Quarters > 3 > balance Sheet > cash
12610099000
Quarters > 3 > balance Sheet > short Term Investments
1291436000
Quarters > 3 > balance Sheet > receivables
4114024000
Quarters > 3 > balance Sheet > inventories
8324339000
Quarters > 3 > balance Sheet > total Current Assets
28788834000
Quarters > 3 > balance Sheet > property Plant Equipment
20369587000
Quarters > 3 > balance Sheet > total Assets
62615166000
Quarters > 3 > balance Sheet > payables
484158000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
15643525000
Quarters > 3 > balance Sheet > total Liabilities
35877570000
Quarters > 3 > balance Sheet > equity
26582367000
Quarters > 3 > balance Sheet > currency_symbol
JPY
Quarters > 3 > cash Flow > net Income
1373000000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
32.98696378027721
Quarters > 3 > ratios > PB
0.014659148832005817
Quarters > 3 > ratios > ROE
5.166247986870394
Quarters > 3 > ratios > ROA
2.193256183334242
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
32413807000
Annuals > 0 > income Statement > cost Of Revenue
15452859000
Annuals > 0 > income Statement > gross Profit
16960947000
Annuals > 0 > income Statement > operating Expenses
29428583000
Annuals > 0 > income Statement > operating Income
2985223000
Annuals > 0 > income Statement > interest Expense
202745000
Annuals > 0 > income Statement > pretax Income
6013099000
Annuals > 0 > income Statement > net Income
4924848000
Annuals > 0 > income Statement > eps
118.29523924911695
Annuals > 0 > income Statement > dividends Per Share
-2100072000
Annuals > 0 > income Statement > shares Outstanding
41631836
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
9.20972658348956
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
JPY
Annuals > 0 > balance Sheet > cash
12032136000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
6643088000
Annuals > 0 > balance Sheet > inventories
12618001000
Annuals > 0 > balance Sheet > total Current Assets
32939848000
Annuals > 0 > balance Sheet > property Plant Equipment
34832518000
Annuals > 0 > balance Sheet > total Assets
92416508000
Annuals > 0 > balance Sheet > payables
460937000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
22271126000
Annuals > 0 > balance Sheet > total Liabilities
52330920000
Annuals > 0 > balance Sheet > equity
40022734000
Annuals > 0 > balance Sheet > currency_symbol
JPY
Annuals > 0 > cash Flow > net Income
4924848000
Annuals > 0 > cash Flow > depreciation
2611092000
Annuals > 0 > cash Flow > change In Working Capital
607059000
Annuals > 0 > cash Flow > cash From Operations
7035243000
Annuals > 0 > cash Flow > capital Expenditures
10932735000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
1627974000
Annuals > 0 > cash Flow > currency_symbol
JPY
Annuals > 0 > ratios > PE
118.29523924911695
Annuals > 0 > ratios > PB
0.00973631598880776
Annuals > 0 > ratios > ROE
12.30512638142112
Annuals > 0 > ratios > ROA
5.328970014751045
Annuals > 0 > ratios > FCF
-3897492000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.12024172291764432
Annuals > 0 > health Score
42
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
26450468000
Annuals > 1 > income Statement > cost Of Revenue
12167891000
Annuals > 1 > income Statement > gross Profit
14282576000
Annuals > 1 > income Statement > operating Expenses
22288102000
Annuals > 1 > income Statement > operating Income
4162365000
Annuals > 1 > income Statement > interest Expense
138783000
Annuals > 1 > income Statement > pretax Income
6974444000
Annuals > 1 > income Statement > net Income
5531261000
Annuals > 1 > income Statement > eps
132.861024390149
Annuals > 1 > income Statement > dividends Per Share
2072413000
Annuals > 1 > income Statement > shares Outstanding
41631931
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
15.736451241618862
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
JPY
Annuals > 1 > balance Sheet > cash
10274773000
Annuals > 1 > balance Sheet > short Term Investments
336724000
Annuals > 1 > balance Sheet > receivables
5778872000
Annuals > 1 > balance Sheet > inventories
12373178000
Annuals > 1 > balance Sheet > total Current Assets
30837713000
Annuals > 1 > balance Sheet > property Plant Equipment
26357666000
Annuals > 1 > balance Sheet > total Assets
76302347000
Annuals > 1 > balance Sheet > payables
460527000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
18147876000
Annuals > 1 > balance Sheet > total Liabilities
42141715000
Annuals > 1 > balance Sheet > equity
34114417000
Annuals > 1 > balance Sheet > currency_symbol
JPY
Annuals > 1 > cash Flow > net Income
5531000000
Annuals > 1 > cash Flow > depreciation
1867985000
Annuals > 1 > cash Flow > change In Working Capital
-4658916000
Annuals > 1 > cash Flow > cash From Operations
2106732000
Annuals > 1 > cash Flow > capital Expenditures
8605246000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
1077078000
Annuals > 1 > cash Flow > currency_symbol
JPY
Annuals > 1 > ratios > PE
132.861024390149
Annuals > 1 > ratios > PB
0.011422586355792038
Annuals > 1 > ratios > ROE
16.213851756575526
Annuals > 1 > ratios > ROA
7.249136124213846
Annuals > 1 > ratios > FCF
-6498514000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-0.2456861632845211
Annuals > 1 > health Score
45
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
25090903000
Annuals > 2 > income Statement > cost Of Revenue
12044235000
Annuals > 2 > income Statement > gross Profit
13046668000
Annuals > 2 > income Statement > operating Expenses
19845661000
Annuals > 2 > income Statement > operating Income
5245242000
Annuals > 2 > income Statement > interest Expense
125060000
Annuals > 2 > income Statement > pretax Income
7759612000
Annuals > 2 > income Statement > net Income
6060057000
Annuals > 2 > income Statement > eps
145.56271723259727
Annuals > 2 > income Statement > dividends Per Share
2484414000
Annuals > 2 > income Statement > shares Outstanding
41631931
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
20.904955074753587
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
JPY
Annuals > 2 > balance Sheet > cash
10533094000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4760363000
Annuals > 2 > balance Sheet > inventories
7329408000
Annuals > 2 > balance Sheet > total Current Assets
23899564000
Annuals > 2 > balance Sheet > property Plant Equipment
18879289000
Annuals > 2 > balance Sheet > total Assets
57242205000
Annuals > 2 > balance Sheet > payables
419764000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
9480425000
Annuals > 2 > balance Sheet > total Liabilities
30883185000
Annuals > 2 > balance Sheet > equity
26211832000
Annuals > 2 > balance Sheet > currency_symbol
JPY
Annuals > 2 > cash Flow > net Income
5024000000
Annuals > 2 > cash Flow > depreciation
1600474000
Annuals > 2 > cash Flow > change In Working Capital
-2812902000
Annuals > 2 > cash Flow > cash From Operations
4004019000
Annuals > 2 > cash Flow > capital Expenditures
4955715000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
4651138000
Annuals > 2 > cash Flow > currency_symbol
JPY
Annuals > 2 > ratios > PE
145.56271723259727
Annuals > 2 > ratios > PB
0.014866373100514302
Annuals > 2 > ratios > ROE
23.119547691286897
Annuals > 2 > ratios > ROA
10.586693856394945
Annuals > 2 > ratios > FCF
-951696000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
-0.037929922251104316
Annuals > 2 > health Score
51
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
17748482000
Annuals > 3 > income Statement > cost Of Revenue
8061183000
Annuals > 3 > income Statement > gross Profit
9687299000
Annuals > 3 > income Statement > operating Expenses
13552865000
Annuals > 3 > income Statement > operating Income
4195617000
Annuals > 3 > income Statement > interest Expense
126646000
Annuals > 3 > income Statement > pretax Income
8183311000
Annuals > 3 > income Statement > net Income
7127629000
Annuals > 3 > income Statement > eps
171.20549788492076
Annuals > 3 > income Statement > dividends Per Share
826530000
Annuals > 3 > income Statement > shares Outstanding
41632010
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
23.63930053285684
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
JPY
Annuals > 3 > balance Sheet > cash
6628901000
Annuals > 3 > balance Sheet > short Term Investments
368090000
Annuals > 3 > balance Sheet > receivables
3501562000
Annuals > 3 > balance Sheet > inventories
4359421000
Annuals > 3 > balance Sheet > total Current Assets
16134487000
Annuals > 3 > balance Sheet > property Plant Equipment
13155817000
Annuals > 3 > balance Sheet > total Assets
39312655000
Annuals > 3 > balance Sheet > payables
64574000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
5809744000
Annuals > 3 > balance Sheet > total Liabilities
19589550000
Annuals > 3 > balance Sheet > equity
19561094000
Annuals > 3 > balance Sheet > currency_symbol
JPY
Annuals > 3 > cash Flow > net Income
7127000000
Annuals > 3 > cash Flow > depreciation
1177432000
Annuals > 3 > cash Flow > change In Working Capital
723340000
Annuals > 3 > cash Flow > cash From Operations
5952778000
Annuals > 3 > cash Flow > capital Expenditures
1614270000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-2731043000
Annuals > 3 > cash Flow > currency_symbol
JPY
Annuals > 3 > ratios > PE
171.20549788492076
Annuals > 3 > ratios > PB
0.01992095194675717
Annuals > 3 > ratios > ROE
36.437783081048536
Annuals > 3 > ratios > ROA
18.130622314875453
Annuals > 3 > ratios > FCF
4338508000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.2444438910324838
Annuals > 3 > health Score
69
Valuation > metrics > PE
11.7
Valuation > metrics > PB
0.011422586355792038
Valuation > final Score
100
Valuation > verdict
49.4% Undervalued
Profitability > metrics > ROE
5.090557461380624
Profitability > metrics > ROA
5.631461710536057
Profitability > metrics > Net Margin
0.2051342687818423
Profitability > final Score
57
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2353051497259941
Risk > metrics > Interest Coverage
38.80053908355795
Risk > final Score
70
Risk > verdict
Low
Liquidity > metrics > Current Ratio
66.96179159962391
Liquidity > metrics > Quick Ratio
40.09435928838049
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
54.087414297453556
Prev Valuations > 2
60.41564346366735
Prev Profitabilities > 0
33
Prev Profitabilities > 1
56
Prev Profitabilities > 2
55
Prev Risks > 0
52
Prev Risks > 1
70
Prev Risks > 2
70
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:31:54.112Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.1304
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-03
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0433
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.271
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-04
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.2955
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
JPY
Earnings History > 4 > eps Actual
0.1946
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-05
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
JPY
Earnings History > 5 > eps Actual
0.0188
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
JPY
Earnings History > 6 > eps Actual
0.2809
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-01
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
JPY
Earnings History > 7 > eps Actual
0.1346
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
JPY
Earnings History > 8 > eps Actual
0.2647
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
JPY
Earnings History > 9 > eps Actual
0.2399
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-03-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Shin Nippon Biomedical Laboratories, Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.1304
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-03-31)
(Last Updated 2024-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.